Ranbaxy spurious drugs case: Japanese owners Daiichi Sankyo considering legal action against Singh brothers Ranbaxy spurious drugs case: Japanese owners Daiichi Sankyo considering legal action ...

Ono picked up Romvimza—previously known by its active ingredient vimseltinib—from its $2.4 billion acquisition of Deciphera ...

Japan's health ministry said on Friday it agreed to buy 1.4 million doses of Daiichi Sankyo's updated COVID-19 vaccine. The purchase is contingent on approval of the shot formulated for the XBB.1. ...

2025 The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. AstraZeneca ...

(AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK ... Monday's Regular trading at $70.08 up $1.02 or 1.48%. For More Such Health News, visit rttnews.com. The views and opinions expressed herein are ...

Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine Approval would give Japan a home-grown mRNA vaccine of the type that has made up the bulk of its COVID inoculations so far.